New methods for the assessment of Parkinson's disease (2005 to 2015): A systematic review

Abstract

Backgro und: The past decade has witnessed a highly dynamic and growing expansion of novel methods aimed at improving the assessment of Parkinson's disease with technology (NAM-PD) in laboratory, clinical, and home environments. However, the current state of NAM-PD regarding their maturity, feasibility, and usefulness in assessing the main PD features has not been systematically evaluated. Methods: A systematic review of articles published in the field from 2005 to 2015 was performed. Of 9,503 publications identified in PubMed and the Web of Science, 848 full papers were evaluated, and 588 original articles were assessed to evaluate the technological, demographic, clinimetric, and technology transfer readiness parameters of NAM-PD. Results: Of the studies, 65% included fewer than 30 patients, < 50% employed a standard methodology to validate diagnostic tests, 8% confirmed their results in a different dataset, and 87% occurred in a clinic or lab.The axial features domain was the most frequently studied, followed by bradykinesia. Rigidity and nonmotor domains were rarely investigated. Only 6% of the systems reached a technology level that justified the hope of being included in clinical assessments in a useful time period. Conclusions: This systematic evaluation provides an overview of the current options for quantitative assessment of PD and what can be expected in the near future. There is a particular need for standardized and collaborative studies to confirm the results of preliminary initiatives, assess domains that are currently underinvestigated, and better validate the existing and upcoming NAM-PD. V C 2016 International Parkinson and Movement Disorder Society

An Overview of Smart Shoes in the Internet of Health Things: Gait and Mobility Assessment in Health Promotion and Disease Monitoring

“…PD has also been in the focus of different review articles [72,73] discussing the applicability and possibilities of especially wearable monitoring technologies. A reason for this is that PD is an excellent model disease for the development of mHealth technologies [74], where the results will be generalizable to a variety of other neurological and musculoskeletal conditions [75].…”

[POSTER] Hybrid Video/Optical See-Through HMD

“…FuglMeyer [15] and Box-and-Blocks tests [8], [28]). Although promising, it has been advocated that correlation with a clinical score is not sufficient to provide evidence for diagnostic validity [32]. Furthermore, it should be noted that patients were not immersed in a 3D environment in this study [24], but that the game was visualized on a laptop.…”

“…Rapid technological developments have resulted in a number of attempts to objectively quantify motor symptoms in laboratory settings or to develop wearable technology for free-living monitoring of for example Parkinson's Disease (PD) [11], [13], [32]. Unfortunately, variations in tasks and environment are often not considered, despite being essential aspects of daily life.…”

Assessing Upper Extremity Motor Dysfunction Using an Augmented Reality Game

“…Rapid technological developments have resulted in a number of attempts to objectively quantify motor symptoms in laboratory settings or to develop wearable technology for free-living monitoring of for example Parkinson's Disease (PD) [11], [13], [32]. Unfortunately, variations in tasks and environment are often not considered, despite being essential aspects of daily life.…”